|
1）Coca SG, Peixoto AJ, Garg AX, et al. The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis. 2007; 50(5): 712-20
|
|
|
|
2）Wald R, Quinn RR, Luo J, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009; 302(11): 1179-85
|
|
|
|
|
|
3）Abbate M, Remuzzi G. Acceleration of recovery in acute renal failure: from cellular mechanisms of tubular repair to innovative targeted therapies. Ren Fail. 1996; 18(3): 377-88
|
|
|
|
|
|
4）Bussolati B, Hauser PV, Carvalhosa R, et al. Contribution of stem cells to kidney repair. Curr Stem Cell Res Ther. 2009; 4(1): 2-8
|
|
|
|
|
|
5）Yanagita M, Okuda T, Endo S, et al. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest. 2006; 116(1): 70-9
|
|
|
|
|
|
6）Kojima I, Tanaka T, Inagi R, et al. Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney. J Am Soc Nephrol. 2007; 18(4): 1218-26
|
|
|
|
|
|
7）Imamura R, Isaka Y, Ichimaru N, et al. Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem Biophys Res Commun. 2007; 353(3): 786-92
|
|
|
|
|
|
8）上田誠二, 甲斐田祐介，山岸昌一，他. 心腎連関の基盤病態としての血管内皮機能障害. 日本内科学会雑誌. 2010; 99: 2571-8
|
|
|
|
|
|
9）Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007; 72(2): 151-6
|
|
|
|
|
|
10）Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int. 2002; 61(3): 855-61
|
|
|
|
|
|
11）Yamamoto T, Tada T, Brodsky SV, et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol. 2002; 282(6): F1150-5
|
|
|
|
|
|
12）Wang W, Mitra A, Poole B, et al. Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am J Physiol Renal Physiol. 2004; 287(5): F1044-8
|
|
|
|
|
|
13）Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol. 2002; 282(6): F1140-9
|
|
|
|
|
|
14）Ichihara A, Inscho EW, Imig JD, et al. Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol. 1998; 274(3 Pt 2): F516-24
|
|
|
|
|
|
15）Mashiach E, Sela S, Winaver J, et al. Renal ischemia-reperfusion injury: contribution of nitric oxide and renal blood flow. Nephron. 1998; 80(4): 458-67
|
|
|
|
|
|
16）Basile DP, Donohoe DL, Roethe K, et al. Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol. 2003; 284(2): F338-48
|
|
|
|
|
|
17）Kang DH, Nakagawa T, Feng L, et al. Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol. 2002; 161(1): 239-48
|
|
|
|
|
|
18）Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens. 2004; 13(1): 1-7
|
|
|
|
|
|
19）Togel, F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005; 289(1): F31-42
|
|
|
|
|
|
20）Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004; 15(7): 1794-804
|
|
|
|
|
|
21）Ueda S, Yamagishi S, Okuda S. New pathways to renal damage: role of ADMA in retarding renal disease progression. J Nephrol. 2010; 23(4): 377-86
|
|
|
|
|
|
22）Nijveldt RJ, Teerlink T, Van Der Hoven B, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr. 2003; 22(1): 23-30
|
|
|
|
|
|
23）Kielstein JT, Simmel S, Bode-Boqer SM, et al. Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition. Kidney Blood Press Res. 2004; 27(3): 143-7
|
|
|
|
|
|
24）Konishi H, Sydow K, Cooke JP. Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury. J Am Coll Cardiol. 2007; 49(10): 1099-105
|
|
|
|
|
|
25）Jacobi J, Sydow K, von Degenfeld G, et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation. 2005; 111(11): 1431-8
|
|
|
|
|
|
26）Thum T, Tsikas D, Stein S, et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol. 2005; 46(9): 1693-701
|
|
|
|
|
|
27）Abedini S, Meinitzer A, Holme I, et al. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int. 2010; 77(1): 44-50
|
|
|
|
|
|
28）中山陽介, 上田誠二, 甲斐田裕介, 他. AKIにおけるADMAの役割の検討. 日本腎臓学会誌. 2010; 52(3): 284
|
|
|
|
|